Approved medicines for paediatric solid tumours in Europe: Lessons from the life cycle of a paediatric investigation plan
Background: Despite the positive changes brought by the Paediatric Regulation in the European Union (EU) in 2007, drug development in children remains challenging. Methods: To better understand the issues encountered to reach an authorisation for paediatric patients, we reviewed the pathway of the 1...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Elsevier
2024-12-01
|
| Σειρά: | EJC Paediatric Oncology |
| Θέματα: | |
| Διαθέσιμο Online: | http://www.sciencedirect.com/science/article/pii/S2772610X24000503 |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|